PRO DEX INC
PDEXNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $66.6M | $53.8M | $46.1M | $42.0M | $38.0M | $34.8M |
| Operating income | $10.7M | $7.2M | $5.8M | $5.1M | $4.5M | $7.1M |
| Net income | $9.0M | $2.1M | $7.1M | $3.9M | $5.8M | $6.1M |
| Total assets | $61.2M | $52.5M | $51.8M | $47.3M | $40.3M | $31.1M |
| Total liabilities | $24.6M | $21.6M | $20.2M | $23.7M | $20.2M | $12.1M |
| Equity | $36.6M | $30.9M | $31.6M | $25.4M | $20.1M | $19.1M |
| EPS (diluted) | $2.67 | $0.60 | $1.95 | $1.02 | $1.48 | $1.50 |
| Shares out. | 3.3M | 3.4M | 3.5M | 3.6M | 3.6M | 3.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 16.1%
- Net margin
- 13.5%
- Return on equity
- 24.5%
- Return on assets
- 14.7%
- Return on capital (ROCE)
- 23.0%
- Liabilities / assets
- 40.1%
- Debt / equity
- 0.67×
- Book value / share
- $11.23
- Revenue growth (YoY)
- 23.7%
- Net income growth (YoY)
- 322.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 8.16safe
- Accruals / assets
- 17.4%high accruals
- Beneish M-Score
- -1.65elevated
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Beneish M-Score elevated — earnings-manipulation screen flag
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 29, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2006
- NT 10-Kmissed a reporting deadline ↗Oct 1, 2002
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2002
- NT 10-Kmissed a reporting deadline ↗Oct 1, 2001
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Van Kirk Richard Lee JrOfficer — Chief Executive Officer | May 21, 2026 | Sell | 1,918 | $62.22 |
| Domingo Angelita RebamontanDirector | Jan 22, 2026 | Grant | 18 | $34.36 |
| Philp Katrina Marie KramerDirector | Nov 21, 2025 | Grant | 900 | $32.73 |
| Van Kirk Richard Lee JrOfficer — Chief Executive Officer | Nov 20, 2025 | Tax withholding | 72 | $30.83 |
| Swenson Nicholas JohnDirector | Nov 20, 2025 | Grant | 1,000 | $0.00 |
| Philp Katrina Marie KramerDirector | Nov 20, 2025 | Grant | 1,000 | $0.00 |
| Hovda DavidDirector | Nov 20, 2025 | Grant | 1,000 | $0.00 |
| Farrell William James IiiDirector | Nov 20, 2025 | Grant | 1,000 | $0.00 |
| Domingo Angelita RebamontanDirector | Nov 20, 2025 | Tax withholding | 72 | $30.83 |
| Charlton AlishaOfficer — Chief Financial Officer | Nov 20, 2025 | Tax withholding | 72 | $30.83 |
| Cabillot Raymond EDirector | Nov 20, 2025 | Grant | 1,000 | $0.00 |
| Domingo Angelita RebamontanDirector | Jul 24, 2025 | Grant | 15 | $42.34 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 191,003 | 6.7 | -19.1% |
| Apr 30, 2026 | 236,192 | 9.9 | +4.0% |
| Apr 15, 2026 | 227,085 | 9.8 | -5.3% |
| Mar 31, 2026 | 239,674 | 9.4 | +8.4% |
| Mar 13, 2026 | 221,031 | 7.2 | -5.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsApr 30, 2026
- Director / officer changeMar 27, 2026
- Entered a material agreement · Completed an acquisition or disposition · New financial obligation · Regulation FD disclosureFeb 12, 2026
- Results of operationsJan 29, 2026
- Director / officer change · Other material eventDec 19, 2025
- Director / officer change · Shareholder voteNov 21, 2025
- Results of operationsOct 30, 2025
- Results of operationsSep 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDFORM SDJun 1, 2026
- 4May 26, 2026
- 144May 21, 2026
- 8-KFORM 8-KApr 30, 2026
- 10-QQUARTERLY REPORTApr 30, 2026
- 8-KFORM 8-KMar 27, 2026
- 8-KFORM 8-KFeb 12, 2026
- 8-KFORM 8-KJan 29, 2026
- 10-QFORM 10-QJan 29, 2026
- 4Jan 23, 2026
- 8-KFORM 8-KDec 19, 2025
- 4Nov 24, 2025
- 4Nov 21, 2025
- 4Nov 21, 2025
- 4Nov 21, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.